Cargando…

Bispecific costimulatory molecules for activation of tumor-killing lymphocytes

Detalles Bibliográficos
Autores principales:	Weth, R, Biburger, M, Wels, W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226110/ https://www.ncbi.nlm.nih.gov/pubmed/15242515 http://dx.doi.org/10.1186/1475-2867-4-S1-S1

Ejemplares similares

A bispecific chimeric antigen receptor molecule enhances T cell activation through dual immunological synapse formation and offsets antigen escape in glioblastoma
por: Hegde, Meenakshi, et al.
Publicado: (2015)

BEAT(® )the bispecific challenge: a novel and efficient platform for the expression of bispecific IgGs
por: Moretti, Pierre, et al.
Publicado: (2013)

Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial.
por: Ahmed, Nabil, et al.
Publicado: (2015)

Costimulatory T cell engagement via a novel bispecific anti-CD137 /anti-HER2 protein
por: Hinner, Marlon J, et al.
Publicado: (2015)

Distinct Costimulatory Molecules Are Required for the Induction of Effector and Memory Cytotoxic T Lymphocytes
por: Liu, Yang, et al.
Publicado: (1997)

Selection of circulating PD-1+ lymphocytes from cancer patients enriches for tumor-reactive and mutation-specific lymphocytes
por: Gros, Alena, et al.
Publicado: (2015)

Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
por: Fortes, Cristina, et al.
Publicado: (2015)

Prevention of breast tumor angiogenesis and metastasis by cytostatic molecules in relevant mouse models
por: Crépin, M, et al.
Publicado: (2003)

Evaluation of Costimulatory Molecules in Peripheral Blood Lymphocytes of Canine Patients with Histiocytic Sarcoma
por: Tagawa, Michihito, et al.
Publicado: (2016)

RANKL expression in human T-lymphocytes requires cooperative signaling through the T-cell receptor and adhesion molecule CD2
por: Harvey, B P, et al.
Publicado: (2010)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

Neuroimmune semaphorins as costimulatory molecules and beyond
por: Chapoval, Svetlana P.
Publicado: (2018)

Altered expression of costimulatory molecules in dementias
por: Busse, Stefan, et al.
Publicado: (2021)

Search for small molecule activators of latent HIV
por: Geleziunas, Romas, et al.
Publicado: (2012)

Modulation of Susceptibility to HIV-1 Infection by the Cytotoxic T Lymphocyte Antigen 4 Costimulatory Molecule
por: Riley, James L., et al.
Publicado: (2000)

Therapeutic targeting truncated adenomatous polyposis coli (APC) proteins for the selective killing of colorectal cancer cells
por: Zhang, Lu, et al.
Publicado: (2014)

Targeting and killing of glioblastoma with activated T cells armed with bispecific antibodies
por: Zitron, Ian M, et al.
Publicado: (2013)

Cytokine Induced Killer cells effectively kill chemo-resistant melanoma cancer stem cells
por: Gammaitoni, Loretta, et al.
Publicado: (2015)

Expression of costimulatory molecules in the bovine corpus luteum
por: Cannon, Matthew J, et al.
Publicado: (2007)

Targeting Costimulatory Molecules to Improve Antitumor Immunity
por: Capece, Daria, et al.
Publicado: (2012)

Signal transduction in T lymphocytes
por: Cantrell, D
Publicado: (2005)

P003 Synthetic antifungal peptide mimic kills Candida albicans by targeting protein glycosylation and synergistically prevents infection
por: Schaefer, Sebastian, et al.
Publicado: (2022)

Pharmacodynamic analysis of an agonistic antibody to the costimulatory receptor GITR
por: Moody, Gordon, et al.
Publicado: (2015)

Dual targeting of the tumor and its associated vasculature using a single bispecific chimeric antigen receptor molecule
por: Byrd, Tiara, et al.
Publicado: (2014)

Epitope specificity appears to be an important determinant of in vivo killing ability of simian immunodeficiency virus (SIV)-specific CD8+ T Cells
por: Pozzi, L, et al.
Publicado: (2012)

Chimeric maternal cells as T lymphocyte targets in pediatric SLE
por: Stevens, Anne M, et al.
Publicado: (2012)

CD95 ligand - death factor and costimulatory molecule?
por: Janssen, O, et al.
Publicado: (2003)

Contributions of Costimulatory Molecule CD137 in Endothelial Cells
por: Yuan, Wei, et al.
Publicado: (2021)

The role of costimulatory molecules in glioma biology and immune microenvironment
por: Wang, Ji, et al.
Publicado: (2022)

In vivo persistence of adoptively transferred TCR gene-transduced lymphocytes with anti-tumor reactivity in patients with MAGE-A4 expressing esophageal cancer
por: Ikeda, Hiroaki, et al.
Publicado: (2013)

GRAIL: a gene related to anergy in lymphocytes
por: Fathman, G, et al.
Publicado: (2003)

Immune correlates of Varlilumab treated cancer patients are consistent with CD27 costimulatory activity
por: Bullock, Timothy, et al.
Publicado: (2014)

Towards targeting protein-protein interfaces with small molecules
por: Gohlke, Holger, et al.
Publicado: (2011)

Crossing of the intestinal barrier by HTLV-1 infected lymphocytes
por: Percher, Florent, et al.
Publicado: (2015)

The molecules and mechanisms of heart development, disease and regeneration
por: Olson, Eric N
Publicado: (2014)

Direct activation of STING in the tumor microenvironment with synthetic cyclic dinucleotide derivatives leads to potent and systemic tumor-specific immunity
por: Corrales, Leticia, et al.
Publicado: (2014)

Increased seroprevalence of lymphocytic choriomeningitis virus infection in mice sampled in illegal waste sites
por: Duh, D, et al.
Publicado: (2014)

Restrictions to HIV-1 replication in resting CD4(+) T lymphocytes
por: Fackler, Oliver
Publicado: (2013)

From immunogenetic polymorphism to functional antitumor lymphocyte mitochondrial dynamics
por: Uzhachenko, Roman, et al.
Publicado: (2015)

Forget cooperativity! – single-molecule signalling with cGMP
por: Kaupp, U Benjamin
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_gassne5909k8bplavd2cq3jqg1